Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 31 - 60 of 118
<  Previous 30    |  1  2  3  4  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
		European Medicines Agency's website: Ganfort - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Ganirelix Gideon Richter - EMA: EPAR PI Finnish Swedish
PL	Resepti	Ganirelix Orifarm 0,25 mg - 0,5 ml injektioneste, liuos, esitäytetty ruisku SPC 2024-01-03
		European Medicines Agency's website: Gardasil - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Gardasil 9 - EMA: EPAR PI Finnish Swedish
PL	Resepti/itsehoito	Gasterix 15 mg, 30 mg enterokapseli, kova SPC 2023-12-01
PL	Itsehoito	Gastrografin 100 mg-ml - 660 mg-ml oraaliliuos SPC 2023-08-01
PL	Itsehoito	Gaviscon oraalisuspensio SPC 2023-12-29
PL	Itsehoito	Gaviscon purutabletti SPC 2022-01-20
PL	Resepti	Gaxenim 0,5 mg kapseli, kova SPC 2024-09-10
		European Medicines Agency's website: Gazyvaro - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Gazyvaro - EMA: EPAR PI Finnish Swedish
PL	Resepti	Geastatin 10, 20, 30, 40 mg tabletti SPC 2005-03-14
PL	Resepti	Geepenil 606 mg injektiokuiva-aine, liuosta varten, (PER) Geepenil 6.06 mg infuusiokuiva-aine, liuosta varten SPC 2021-03-10
PL	Resepti	Gefina 5 mg tabletti SPC 2021-03-12
PL	Resepti	Gefitinib Accord 250 mg tabletti, kalvopäällysteinen SPC 2022-03-16
PL	Resepti	Gefitinib Avansor 250 mg tabletti, kalvopäällysteinen SPC 2023-01-27
PL	Resepti	Gefitinib Stada 250 mg tabletti, kalvopäällysteinen SPC 2022-10-20
PL	Resepti	Gelofusine 40mg-ml infuusioneste SPC FI 2022-03-18
PL	Resepti	Gemcitabin Actavis 40 mg-ml infuusiokonsentraatti SPC 2011-08-02
PL	Resepti	Gemcitabin Sandoz 40 mg-ml infuusiokonsentraatti, liuosta varten SPC 2024-05-02
PL	Resepti	Gemcitabin Sun 10 mg-ml infuusioneste, liuos SPC 2024-05-24
PL	Resepti	Gemcitabine Accord 100 mg-ml infuusiokonsentraatti, liuosta varten SPC 2024-01-10
PL	Resepti	Gemkabi 38 mg-ml infuusiokonsentraatti, liuosta varten SPC 2024-02-15
		European Medicines Agency's website: Gencebok (ent. Neocaf) - EMA: EPAR PI Finnish Swedish
PL	Resepti	Genotropin 5 mg, 12 mg injektiokuiva-aine ja liuotin, liuosta varten SPC 2024-05-14
PL	Resepti	Gensumycin 40 mg-ml injektioneste, liuos SPC 2024-04-12
PL	Resepti	Gentacoll 1.3 mg-cm2 implantaatti SPC 2020-09-15
		European Medicines Agency's website: Genvoya - EMA: EPAR PI Finnish Swedish
PL	Resepti	Gepretix 100 mg kapseli, pehmeä SPC 2024-02-20
<  Previous 30    |  1  2  3  4  |  Next 30   >